For easier and more efficient research
With its products for life science research in the pharmaceutical and biotechnology industries as well as academia, the Bioscience Business Unit accounts for about 20% of the division’s total revenues. It is focused on offering solutions that help scientists to conduct life science research easily, efficiently and economically.
The Bioscience Business Unit provides an increasing number of tools and services to support researchers seeking to understand complex biological systems as well as to identify and characterize new therapeutic targets.
Tools and services from our Bioscience Business Unit help researchers meet increasing demands as pharmaceutical researchers come under increasing competitive pressure to screen and identify new drugs with more speed and accuracy.
Therefore, our goal is to create products and services that simplify the work flow for researchers, offering consolidated and validated solutions. The business unit’s products help to advance life science research in a wide variety of areas ranging from neuroscience, infectious disease, oncology, and metabolic disorders to stem cells, cell signaling, nuclear function, and chromatin biology.
Products for protein research and cell biology
The Bioscience Business Unit sells thousands of products, primarily into the protein research and cell biology markets. These include instruments, consumable devices, reagents and services to help customers better understand diseases and biological functions. Their work typically involves conducting experiments on biological samples, such as cells, proteins, and nucleic acids. Merck Millipore also offers a wide variety of kits that improve research productivity and efficiency. Kits enhance research productivity by combining in one box all the disposables, reagents, and protocols needed to reliably and reproducibly conduct a particular experiment.
Measuring the effect of drugs on protein biomarkers
Within the protein research market, we offer multiplex immunoassay and ELISA kits, protein detection products, and flow cytometry instruments and kits. Researchers use our multiplex immunoassay kits to understand which proteins may be indicative of a disease state, measure how a drug affects protein biomarkers, and determine what side effects a drug creates. We are developing multiplex kits, reagents, and assays for researchers studying immunology, inflammation, and metabolic diseases (e.g. diabetes, obesity, cardiovascular disorders).
An integrated range
The Bioscience Business Unit is increasingly seeking to integrate instrumentation, reagent kits, validated protocols and technical support. One example of this approach is in flow cytometry, where we are bringing the advantages to the bench tops of cell biologists.
A major challenge for our customers is to find promising drug candidates faster and then ensure that they will not generate unwanted or unexpected side effects in clinical trials or when they are commercially available on the market. To improve the efficiency and economy of this research, customers outsource research work to the Bioscience Business Unit rather than conduct the work in-house. We provide services to identify disease targets and better understand how to improve the efficacy of drugs on targeted patient groups and prevent side effects.
Merck Millipore’s service offering helps customers better understand the safety and efficacy of biologic drugs and vaccines. With the increasing development of biologics, companies are leveraging our expertise to help them evaluate the efficacy of these drugs. We offer our customers a broad range of services to assist with evaluating and advancing these therapeutics from the drug development pipeline to the market. The offering includes biomarker analytical services, assay transfer/development, validation and sample analysis, pharmacokinetics, toxicokinetics, immunogenicity, biological potency, and vaccine services.
back
